<DOC>
	<DOCNO>NCT00672724</DOCNO>
	<brief_summary>The purpose study evaluate subjectively report treatment effect ramelteon , daily ( QD ) , adult chronic insomnia .</brief_summary>
	<brief_title>Efficacy Ramelteon Adults With Chronic Insomnia</brief_title>
	<detailed_description>Insomnia characterize difficulty initiate maintain sleep , complaint non-restorative non-refreshing sleep . Transient insomnia affect approximately one-third one-half US population , base result 2 survey representative sample adult US population conduct Gallup Organization respondent ask `` ever difficulty sleep . '' Based report `` regular '' `` frequent '' sleep difficulty , result study suggest approximately one-tenth US population experience chronic insomnia . The ideal treatment insomnia would reduce latency onset sleep increase total sleep time , without negative impact sleep architecture without safety concern next-day effect . Ramelteon global development Takeda Chemical Industries , Ltd. , treatment transient chronic insomnia treatment Circadian Rhythm Sleep Disorders . This study conduct assess treatment effect ramelteon adult use daily entry information interactive voice response system . Study participation study anticipate 1 month .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Inclusion Criteria Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . Has primary chronic insomnia define Diagnostic Statistical Manual Mental Disorders , 4th Edition Revised least 3 month . Reports history subjective sleep latency great equal 60 min subjective total sleep time le 6.5 hour . Habitual bedtime 10:00 PM 1:00 AM . Willing fixed bedtime agree go bed within plus minus 30 minute habitual bedtime entire study . Consistent access touch tone phone willing complete telephone questionnaire twice daily participation study . Willing remain bed least 6.5 hour night entire study . Used pharmacological assistance sleep 04 time per week last 3 month . Must complete morning questionnaire least 4 first 7 morning Screening Visit 1 . On least 3 first 5 night singleblind placebo treatment , subject must subjective sleep latency great equal 45 minute . On least 3 first 5 night singleblind placebo treatment , subject must subjective total sleep time le 6.5 hour . Exclusion Criteria Known hypersensitivity ramelteon related compound , include melatonin , 5hydroxytryptophan . Participated investigational study and/or take investigational drug within 30 day prior first dose singleblind study medication . Sleep schedule change require employment ( eg , shift worker ) within 3 month prior first night singleblind study medication . Has fly across great 3 time zone within 7 day prior screen , travel across 2 time zone course study . Participated weight loss program substantially alter exercise routine within 30 day prior first night singleblind study medication . Ever history seizure , sleep apnea , and/or chronic obstructive pulmonary disease . History psychiatric disorder within past 6 month . History fibromyalgia . History drug addiction drug abuse within past 12 month . History alcohol abuse within past 12 month , define Diagnostic Statistical Manual Mental Disorders , 4th Edition Revised and/or regularly consume 2 alcoholic drink per day . Current significant hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , hematologic , metabolic disease , unless currently control stable protocolallowed medication , within 30 day prior first night singleblind study medication . Uses tobacco product product may interfere sleep wake cycle nightly awakening . Any clinically important abnormal finding determine medical history , physical examination , electrocardiogram , clinical laboratory test , determine investigator . Positive hepatitis panel . Any additional condition ( ) Investigator 's opinion would : affect sleep/wake function prohibit subject complete study indicate continuation study would best interest subject . Is required take continue take disallow medication , prescription medication , herbal treatment overthe counter medication , include : Anxiolytics Central nervous system active drug Hypnotics Narcotic analgesic Antidepressants Beta blocker Anticonvulsants St. John 's Wort Sedating H1 antihistamines Kavakava Systemic steroid Ginkgobiloba Respiratory stimulant Overthecounter prescription stimulant Decongestants Overthecounter prescription diet aid Antipsychotics Melatonin drug supplement know affect sleep/wake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Sleep Disorder</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>